doxycycline hyclate 200 MG Delayed Release Oral Tablet
- RxCUI
- 1423080
- RxNorm name
- doxycycline hyclate 200 MG Delayed Release Oral Tablet
- Display name
- Doxycycline (Oral Pill)
- Full name
- doxycycline hyclate 200 MG Delayed Release Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 200 mg
- Dose form
- DR Tab
- Route
- Oral Pill
- Updated
- 2026-11-12 18:36:18
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062013
- Active start
- 062013
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline hyclate | 200 MG / 1 EACH | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Delayed Release Oral Tablet | 10312 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | doxycycline hyclate 200 MG Delayed Release Oral Tablet | 1 | NAMES |
| RxNorm Name | doxycycline hyclate 200 MG Delayed Release Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 6 | CODES | |
| RxCUI | 1423080 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0591-4575-60 | 0591-4575 | Doxycycline Hyclate Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA090134 |
| 23155-611-04 | 23155-611 | DOXYCYCLINE HYCLATE doxycycline hyclate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA200856 |
| 23155-611-06 | 23155-611 | DOXYCYCLINE HYCLATE doxycycline hyclate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA200856 |
| 43547-325-06 | 43547-325 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | ANDA207494 |
| 43547-325-10 | 43547-325 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | ANDA207494 |
| 43547-325-50 | 43547-325 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | ANDA207494 |
| 46708-484-30 | 46708-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Limited | ANDA213075 |
| 46708-484-31 | 46708-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Limited | ANDA213075 |
| 46708-484-60 | 46708-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Limited | ANDA213075 |
| 46708-484-71 | 46708-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Limited | ANDA213075 |
| 62332-484-30 | 62332-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | ANDA213075 |
| 62332-484-31 | 62332-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | ANDA213075 |
| 62332-484-60 | 62332-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | ANDA213075 |
| 62332-484-71 | 62332-484 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | ANDA213075 |
| 68308-716-30 | 68308-716 | Doxycycline Hyclate Doxycycline Hyclate | Mayne Pharma Commercial LLC | NDA050795 |
| 68308-716-60 | 68308-716 | Doxycycline Hyclate Doxycycline Hyclate | Mayne Pharma Commercial LLC | NDA050795 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA090134 | 0591-4575 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | Actavis Pharma, Inc. |
| ANDA200856 | 23155-611 | DOXYCYCLINE HYCLATE doxycycline hyclate | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| ANDA207494 | 43547-325 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | ANDA | Solco Healthcare US LLC |
| ANDA213075 | 46708-484 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | Alembic Pharmaceuticals Limited |
| NDA050795 | 68308-716 | Doxycycline Hyclate Doxycycline Hyclate | NDA AUTHORIZED GENERIC | Mayne Pharma Commercial LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f5ee43b2-d6ca-4819-a3d7-07f8421015d7 | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 34 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | 20251216 |
| cd2ab9b8-9619-4199-8a5d-83377b3274d1 | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 15 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | 20250414 |
| 3ae4ca12-be39-46b9-bc4c-f8356776c175 | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | 20260428 |
| c2b08332-3256-4658-965a-ede3d973a388 | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | 20250401 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | 20251031 |
| 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | 20230410 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3ae4ca12-be39-46b9-bc4c-f8356776c175 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20260428 |
| f5ee43b2-d6ca-4819-a3d7-07f8421015d7 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited | 20251216 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20251031 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20251031 |
| f5ee43b2-d6ca-4819-a3d7-07f8421015d7 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | USV Private Limited | 20251017 |
| cd2ab9b8-9619-4199-8a5d-83377b3274d1 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Mayne Pharma Commercial LLC | Mayne Pharma International Pty Ltd | Catalent Greenville, Inc. | 20250414 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| f5ee43b2-d6ca-4819-a3d7-07f8421015d7 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | USV Private Limited | 20231031 |
| 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Alembic Pharmaceuticals Limited | 20230410 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20220922 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline hyclate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline hyclate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 200 MG (expressed as doxycycline hyclate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA090134 |
| CODES | ANDA | ANDA200856 |
| CODES | ANDA | ANDA207494 |
| CODES | ANDA | ANDA213075 |
| CODES | VUID | 4032509 |
| NAMES | Prescribable Synonym | doxycycline hyclate 200 MG Delayed Release Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |